全文获取类型
收费全文 | 918678篇 |
免费 | 77262篇 |
国内免费 | 6501篇 |
专业分类
耳鼻咽喉 | 13175篇 |
儿科学 | 25243篇 |
妇产科学 | 25939篇 |
基础医学 | 130678篇 |
口腔科学 | 26545篇 |
临床医学 | 83284篇 |
内科学 | 171750篇 |
皮肤病学 | 17608篇 |
神经病学 | 72875篇 |
特种医学 | 37449篇 |
外国民族医学 | 212篇 |
外科学 | 141957篇 |
综合类 | 36200篇 |
一般理论 | 265篇 |
预防医学 | 70260篇 |
眼科学 | 22218篇 |
药学 | 71509篇 |
59篇 | |
中国医学 | 5188篇 |
肿瘤学 | 50027篇 |
出版年
2018年 | 9356篇 |
2017年 | 7727篇 |
2016年 | 8215篇 |
2015年 | 10580篇 |
2014年 | 14863篇 |
2013年 | 19844篇 |
2012年 | 27222篇 |
2011年 | 29176篇 |
2010年 | 17045篇 |
2009年 | 15442篇 |
2008年 | 25826篇 |
2007年 | 27939篇 |
2006年 | 27897篇 |
2005年 | 27442篇 |
2004年 | 25819篇 |
2003年 | 24895篇 |
2002年 | 23637篇 |
2001年 | 37244篇 |
2000年 | 37970篇 |
1999年 | 32455篇 |
1998年 | 9856篇 |
1997年 | 9171篇 |
1996年 | 8782篇 |
1995年 | 8805篇 |
1994年 | 8414篇 |
1992年 | 27153篇 |
1991年 | 26573篇 |
1990年 | 26024篇 |
1989年 | 25021篇 |
1988年 | 23489篇 |
1987年 | 23106篇 |
1986年 | 21942篇 |
1985年 | 21246篇 |
1984年 | 16439篇 |
1983年 | 14006篇 |
1982年 | 8853篇 |
1981年 | 8201篇 |
1979年 | 16723篇 |
1978年 | 12073篇 |
1977年 | 10136篇 |
1976年 | 9291篇 |
1975年 | 10108篇 |
1974年 | 12614篇 |
1973年 | 12117篇 |
1972年 | 11523篇 |
1971年 | 10668篇 |
1970年 | 10194篇 |
1969年 | 9894篇 |
1968年 | 8890篇 |
1967年 | 8211篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
目的 比较腹腔镜和开腹手术治疗长径5~10 cm的中危胃间质瘤的安全性和有效性,并评估患者术后使用伊马替尼辅助治疗是否有明显益处。方法 回顾性分析2010年1月—2020年7月在南京大学医学院附属鼓楼医院接受手术治疗的72例长径在5~10 cm的中危胃间质瘤患者资料。其中腹腔镜手术组28例,开腹手术组44例。比较两组患者基本资料、病理特征、围手术期结果、住院总费用。对比术后使用和不使用伊马替尼辅助治疗的生存率。结果 开腹组和腹腔镜组临床病理特征差异无统计学意义(P>0.05)。腹腔镜组术后并发症发生率为32.1%(9/28),开腹组为52.3%(23/44),两组比较差异无统计学意义(P=0.094)。与开腹组相比,腹腔镜组总住院时间明显缩短[(12.5±3.2) d比(15.0±3.5) d,P=0.004];术后中位住院天数明显缩短(7.5 d 比 9.0 d,P=0.006);首次排气时间明显缩短(P=0.003)。中位随访时间58个月(13~129个月),期间未出现与肿瘤相关的死亡病例。开腹组有2例死亡,分别因乳腺癌和心脏病;腹腔镜组有1例死亡,死亡原因与胃间质瘤无关。72例患者中,40例术后接受伊马替尼辅助治疗,开腹组22例(50.0%),腹腔镜组18例(64.3%),两组接受伊马替尼辅助治疗的患者例数占比差异无统计学意义(χ2=1.414,P=0.234)。术后使用伊马替尼辅助治疗组总体生存率与未使用伊马替尼辅助治疗组相比差异有统计学意义 (P=0.015)。结论 与开腹手术相比,腹腔镜治疗长径在5~10 cm的中危胃间质瘤是一种安全有效的方法。实现R0切除的长径在5~10 cm的中危胃间质瘤患者术后使用伊马替尼辅助治疗未增加生存率,且未使用伊马替尼者未出现与肿瘤相关的死亡、复发及转移。 相似文献
3.
Given that the global population of elderly individuals is expanding and the difficulty of recovery, hip fractures will be a huge challenge and a critical health issue for all of humanity. Although people have spent more time at home during the coronavirus disease 2019 (COVID-19) pandemic, hip fractures show no sign of abating. Extensive studies have shown that patients with hip fracture and COVID-19 have a multifold increase in mortality compared to those uninfected and a more complex clinical condition. At present, no detailed research has systematically analyzed the relationship between these two conditions and proposed a comprehensive solution. This article aims to systematically review the impact of COVID-19 on hip fracture and provide practical suggestions. We found that hip fracture patients with COVID-19 have higher mortality rates and more complicated clinical outcomes. Indirectly, COVID-19 prevents hip fracture patients from receiving regular medical treatment. With regard to the problems we encounter, we provide clinical recommendations based on existing research evidence and a clinical flowchart for the management of hip fracture patients who are COVID-19 positive. Our study will help clinicians adequately prepare in advance when dealing with such patients and optimize treatment decisions. 相似文献
5.
6.
Boffa Joseph W. Tock Jamie L. Morabito Danielle M. Schmidt Norman B. 《Cognitive therapy and research》2022,46(5):1016-1029
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study... 相似文献
7.
8.
Guo-Quan Shi Huajun Zhu & Zhen-Guo Yan 《Communications In Computational Physics》2022,31(4):1215-1241
A priori subcell limiting approach is developed for high-order flux reconstruction/correction procedure via reconstruction (FR/CPR) methods on two-dimensional unstructured quadrilateral meshes. Firstly, a modified indicator based on
modal energy coefficients is proposed to detect troubled cells, where discontinuities
exist. Then, troubled cells are decomposed into nonuniform subcells and each subcell has one solution point. A second-order finite difference shock-capturing scheme
based on nonuniform nonlinear weighted (NNW) interpolation is constructed to perform the calculation on troubled cells while smooth cells are calculated by the CPR
method. Numerical investigations show that the proposed subcell limiting strategy on
unstructured quadrilateral meshes is robust in shock-capturing. 相似文献
9.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
10.